Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2026-01-08 @ 10:58 PM
Study NCT ID:
NCT00656734
Status:
COMPLETED
Last Update Posted:
2013-05-14
First Post:
2008-04-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer.
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-04
Start Date Type:
None
Primary Completion Date:
2010-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-06
Completion Date Type:
ACTUAL
First Submit Date:
2008-04-03
First Submit QC Date:
None
Study First Post Date:
2008-04-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-05-13
Last Update Post Date:
2013-05-14
Last Update Post Date Type:
ESTIMATED